Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
News
(186)
Asset
(112)
SEC filing
(89)
Event
(59)
Filter by content year
(-)
2021
(446)
Filter by form group
Filter by category
Filter by category
Search
Asset
Berichte 2021
20-F
83.3 MB
BioNTech Geschäftsbericht 2021
14.9 MB
Nachhaltigkeitsbericht 2021
6.4 MB
Asset
2021 Reports
20-F
83.3 MB
BioNTech Annual Report 2021
14.8 MB
2021 Sustainability Report
6.4 MB
Event
39th Annual JP Morgan Healthcare Conference
Event
39th Annual JP Morgan Healthcare Conference
News
BioNTech präsentiert auf der 39. Annual J.P. Morgan Healthcare Conference
News
BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
News
BioNTech veröffentlicht Daten zu neuartigem mRNA-Impfstoffansatz gegen Autoimmunkrankheiten in Science
News
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
News
Pfizer-BioNTech COVID-19-Impfstoff löst in vitro neutralisierende Antikörperantwort gegen SARS-CoV-2 mit einer Mutation aus, die mit einer schnellen Übertragung assoziiert wird
News
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
Pagination
Page 1
Next page
››